138 related articles for article (PubMed ID: 16254790)
21. [Indications and efficacy of biologics in inflammatory arthritis].
Combe B
Bull Acad Natl Med; 2012 Oct; 196(7):1279-92; discussion 1293. PubMed ID: 23815014
[TBL] [Abstract][Full Text] [Related]
22. [gp130F759 mouse].
Ishihara K; Hirano T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():68-72. PubMed ID: 15799320
[No Abstract] [Full Text] [Related]
23. Treatment of rheumatoid arthritis.
Gaffo A; Saag KG; Curtis JR
Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
[TBL] [Abstract][Full Text] [Related]
24. Inflammation 2009-Ninth World Congress. Advances in inflammation research: part 2. 6-10 July 2009, Tokyo, Japan.
Mason VL
IDrugs; 2009 Sep; 12(9):532-4. PubMed ID: 19697266
[No Abstract] [Full Text] [Related]
25. Rituximab and abatacept for rheumatoid arthritis.
BMJ Group
Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
[TBL] [Abstract][Full Text] [Related]
26. Inflammation 2005 - Seventh World Congress. Respiratory inflammation.
Parnham MJ
IDrugs; 2005 Oct; 8(10):783-6. PubMed ID: 16254789
[TBL] [Abstract][Full Text] [Related]
27. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.
Huang JH; Tykocinski ML
Int Immunol; 2001 Apr; 13(4):529-39. PubMed ID: 11282992
[TBL] [Abstract][Full Text] [Related]
28. [Biological agents].
Amano K
Nihon Rinsho; 2009 Mar; 67(3):593-8. PubMed ID: 19280938
[TBL] [Abstract][Full Text] [Related]
29. How does abatacept really work in rheumatoid arthritis?
Bonelli M; Scheinecker C
Curr Opin Rheumatol; 2018 May; 30(3):295-300. PubMed ID: 29401118
[TBL] [Abstract][Full Text] [Related]
30. Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker.
Poirier N; Blancho G; Vanhove B
Immunotherapy; 2010 Sep; 2(5):625-36. PubMed ID: 20874646
[TBL] [Abstract][Full Text] [Related]
31. Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway.
Rossato E; Ben Mkaddem S; Kanamaru Y; Hurtado-Nedelec M; Hayem G; Descatoire V; Vonarburg C; Miescher S; Zuercher AW; Monteiro RC
Arthritis Rheumatol; 2015 Jul; 67(7):1766-77. PubMed ID: 25833812
[TBL] [Abstract][Full Text] [Related]
32. Signal transduction networks in rheumatoid arthritis.
Hammaker D; Sweeney S; Firestein GS
Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii86-9. PubMed ID: 14532158
[TBL] [Abstract][Full Text] [Related]
33. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
34. Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis.
Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):276-84. PubMed ID: 19228144
[TBL] [Abstract][Full Text] [Related]
35. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.
Fiocco U; Sfriso P; Oliviero F; Pagnin E; Scagliori E; Campana C; Dainese S; Cozzi L; Punzi L
Autoimmun Rev; 2008 Oct; 8(1):76-82. PubMed ID: 18718877
[TBL] [Abstract][Full Text] [Related]
36. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
37. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
Andreakos E; Foxwell B; Feldmann M
Immunol Rev; 2004 Dec; 202():250-65. PubMed ID: 15546398
[TBL] [Abstract][Full Text] [Related]
38. The role of adhesion and costimulation molecules in graft-versus-host disease.
Schlegel PG
Acta Haematol; 1997; 97(1-2):105-17. PubMed ID: 8980616
[TBL] [Abstract][Full Text] [Related]
39. Abatacept.
Vital EM; Emery P
Drugs Today (Barc); 2006 Feb; 42(2):87-93. PubMed ID: 16541185
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of down-regulatory CTLA-4 molecule on T lymphocytes from rheumatoid synovial compartment.
Liu MF; Yang CY; Li JS; Lai KA; Chao SC; Lei HY
Scand J Immunol; 1999 Jul; 50(1):68-72. PubMed ID: 10404054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
